Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Neurocognitive Function and Fetal Alcohol Spectrum Disorder in Offenders with Mental Disorders.

Mela M, Flannigan K, Anderson T, Nelson M, Krishnan S, Chizea C, Takahashi S, Sanjanwala R.

J Am Acad Psychiatry Law. 2020 Feb 12. pii: JAAPL.003886-20. doi: 10.29158/JAAPL.003886-20. [Epub ahead of print]

PMID:
32051201
2.

The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins.

Erickson SL, Alston L, Nieves K, Chang TKH, Mani S, Flannigan KL, Hirota SA.

FASEB J. 2020 Feb;34(2):2198-2212. doi: 10.1096/fj.201902083RR. Epub 2019 Dec 17.

PMID:
31907988
3.

Vancomycin relieves mycophenolate mofetil-induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity.

Taylor MR, Flannigan KL, Rahim H, Mohamud A, Lewis IA, Hirota SA, Greenway SC.

Sci Adv. 2019 Aug 7;5(8):eaax2358. doi: 10.1126/sciadv.aax2358. eCollection 2019 Aug.

4.

Pregnane X Receptor Activation Triggers Rapid ATP Release in Primed Macrophages That Mediates NLRP3 Inflammasome Activation.

Hudson G, Flannigan KL, Venu VKP, Alston L, Sandall CF, MacDonald JA, Muruve DA, Chang TKH, Mani S, Hirota SA.

J Pharmacol Exp Ther. 2019 Jul;370(1):44-53. doi: 10.1124/jpet.118.255679. Epub 2019 Apr 19.

5.

Assessing for Fetal Alcohol Spectrum Disorder.

Coons-Harding KD, Flannigan K, Burns C, Rajani H, Symes B.

J Popul Ther Clin Pharmacol. 2019 Jan 23;26(1):e39-e55. doi: 10.22374/1710-6222.26.1.4.

PMID:
31002487
6.

Combined IL-2 Immunocomplex and Anti-IL-5 mAb Treatment Expands Foxp3+ Treg Cells in the Absence of Eosinophilia and Ameliorates Experimental Colitis.

Abo H, Flannigan KL, Geem D, Ngo VL, Harusato A, Denning TL.

Front Immunol. 2019 Mar 14;10:459. doi: 10.3389/fimmu.2019.00459. eCollection 2019.

7.

An intact microbiota is required for the gastrointestinal toxicity of the immunosuppressant mycophenolate mofetil.

Flannigan KL, Taylor MR, Pereira SK, Rodriguez-Arguello J, Moffat AW, Alston L, Wang X, Poon KK, Beck PL, Rioux KP, Jonnalagadda M, Chelikani PK, Galipeau HJ, Lewis IA, Workentine ML, Greenway SC, Hirota SA.

J Heart Lung Transplant. 2018 Sep;37(9):1047-1059. doi: 10.1016/j.healun.2018.05.002. Epub 2018 May 23.

PMID:
30173823
8.

Segmented filamentous bacteria-induced immune responses: a balancing act between host protection and autoimmunity.

Flannigan KL, Denning TL.

Immunology. 2018 May 17. doi: 10.1111/imm.12950. [Epub ahead of print] Review.

9.

Neurocognitive functioning in young offenders with Fetal Alcohol Spectrum Disorder.

Flannigan K, Pei J, Burke A, Frenzel R, Rasmussen C.

Int J Law Psychiatry. 2019 Jul - Aug;65:101347. doi: 10.1016/j.ijlp.2018.04.007. Epub 2018 May 1. No abstract available.

PMID:
29724514
10.

Fetal Alcohol Spectrum Disorder and the criminal justice system: A systematic literature review.

Flannigan K, Pei J, Stewart M, Johnson A.

Int J Law Psychiatry. 2018 Mar - Apr;57:42-52. doi: 10.1016/j.ijlp.2017.12.008. Epub 2018 Feb 3. Review. No abstract available.

11.

Deferred diagnosis in children assessed for fetal alcohol spectrum disorder.

Flannigan K, Gill K, Pei J, Andrew G, Rajani H, McFarlane A, O'Riordan T, Symes B, Rasmussen C.

Appl Neuropsychol Child. 2019 Jul-Sep;8(3):213-222. doi: 10.1080/21622965.2018.1427094. Epub 2018 Feb 12.

PMID:
29432031
12.

Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in a Pediatric Heart Transplant Patient.

Flannigan KL, Rajbar T, Moffat A, McKenzie LS, Dicke F, Rioux K, Workentine ML, Louie TJ, Hirota SA, Greenway SC.

Front Cardiovasc Med. 2017 Apr 4;4:17. doi: 10.3389/fcvm.2017.00017. eCollection 2017.

13.

Constitutive androstane receptor regulates the intestinal mucosal response to injury.

Hudson GM, Flannigan KL, Erickson SL, Vicentini FA, Zamponi A, Hirota CL, Alston L, Altier C, Ghosh S, Rioux KP, Mani S, Chang TK, Hirota SA.

Br J Pharmacol. 2017 Jun;174(12):1857-1871. doi: 10.1111/bph.13787. Epub 2017 Apr 19.

14.

Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity.

Ranhotra HS, Flannigan KL, Brave M, Mukherjee S, Lukin DJ, Hirota SA, Mani S.

Nucl Receptor Res. 2016;3. pii: 101199.

15.

IL-17A-mediated neutrophil recruitment limits expansion of segmented filamentous bacteria.

Flannigan KL, Ngo VL, Geem D, Harusato A, Hirota SA, Parkos CA, Lukacs NW, Nusrat A, Gaboriau-Routhiau V, Cerf-Bensussan N, Gewirtz AT, Denning TL.

Mucosal Immunol. 2017 May;10(3):673-684. doi: 10.1038/mi.2016.80. Epub 2016 Sep 14.

16.

Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APCMin/+ Mouse Model of Intestinal Tumorigenesis.

Paul-Clark M, Elsheikh W, Kirkby N, Chan M, Devchand P, Agbor TA, Flannigan KL, Cheadle C, Freydin M, Ianaro A, Mitchell JA, Wallace JL.

PLoS One. 2016 Feb 24;11(2):e0147289. doi: 10.1371/journal.pone.0147289. eCollection 2016.

17.

Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage.

Medina-Contreras O, Harusato A, Nishio H, Flannigan KL, Ngo V, Leoni G, Neumann PA, Geem D, Lili LN, Ramadas RA, Chassaing B, Gewirtz AT, Kohlmeier JE, Parkos CA, Towne JE, Nusrat A, Denning TL.

J Immunol. 2016 Jan 1;196(1):34-8. doi: 10.4049/jimmunol.1501312. Epub 2015 Nov 20.

18.

Gaseous mediators in resolution of inflammation.

Wallace JL, Ianaro A, Flannigan KL, Cirino G.

Semin Immunol. 2015 May;27(3):227-33. doi: 10.1016/j.smim.2015.05.004. Epub 2015 Jun 18. Review.

PMID:
26095908
19.

Hydrogen sulfide-based anti-inflammatory and chemopreventive therapies: an experimental approach.

Flannigan KL, Wallace JL.

Curr Pharm Des. 2015;21(21):3012-22. Review.

PMID:
26004409
20.

Intestinal Antigen-Presenting Cells: Key Regulators of Immune Homeostasis and Inflammation.

Flannigan KL, Geem D, Harusato A, Denning TL.

Am J Pathol. 2015 Jul;185(7):1809-19. doi: 10.1016/j.ajpath.2015.02.024. Epub 2015 May 11. Review.

21.

Technique for Tube Extender Implantation.

Ho DK, Flannigan KP, Levin AV.

J Glaucoma. 2016 Mar;25(3):e265-7. doi: 10.1097/IJG.0000000000000272.

PMID:
25943733
22.

Phenotypic and functional profiling of mouse intestinal antigen presenting cells.

Harusato A, Flannigan KL, Geem D, Denning TL.

J Immunol Methods. 2015 Jun;421:20-26. doi: 10.1016/j.jim.2015.03.023. Epub 2015 Apr 17. Review.

23.

Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID.

Blackler RW, De Palma G, Manko A, Da Silva GJ, Flannigan KL, Bercik P, Surette MG, Buret AG, Wallace JL.

Am J Physiol Gastrointest Liver Physiol. 2015 Jun 15;308(12):G994-1003.

24.

Harnessing regulatory T cells for the treatment of inflammatory bowel disease.

Geem D, Harusato A, Flannigan K, Denning TL.

Inflamm Bowel Dis. 2015 Jun;21(6):1409-18. doi: 10.1097/MIB.0000000000000343. Review.

25.

Hydrogen sulfide protects from colitis and restores intestinal microbiota biofilm and mucus production.

Motta JP, Flannigan KL, Agbor TA, Beatty JK, Blackler RW, Workentine ML, Da Silva GJ, Wang R, Buret AG, Wallace JL.

Inflamm Bowel Dis. 2015 May;21(5):1006-17. doi: 10.1097/MIB.0000000000000345.

PMID:
25738373
26.

Proresolution effects of hydrogen sulfide during colitis are mediated through hypoxia-inducible factor-1α.

Flannigan KL, Agbor TA, Motta JP, Ferraz JG, Wang R, Buret AG, Wallace JL.

FASEB J. 2015 Apr;29(4):1591-602. doi: 10.1096/fj.14-266015. Epub 2014 Dec 30.

PMID:
25550470
27.

Impaired hydrogen sulfide synthesis and IL-10 signaling underlie hyperhomocysteinemia-associated exacerbation of colitis.

Flannigan KL, Agbor TA, Blackler RW, Kim JJ, Khan WI, Verdu EF, Ferraz JG, Wallace JL.

Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13559-64. doi: 10.1073/pnas.1413390111. Epub 2014 Sep 3.

28.

Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer.

Elsheikh W, Blackler RW, Flannigan KL, Wallace JL.

Nitric Oxide. 2014 Sep 15;41:131-7. doi: 10.1016/j.niox.2014.04.006. Epub 2014 Apr 18.

PMID:
24747869
29.

Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics.

Wallace JL, Blackler RW, Chan MV, Da Silva GJ, Elsheikh W, Flannigan KL, Gamaniek I, Manko A, Wang L, Motta JP, Buret AG.

Antioxid Redox Signal. 2015 Feb 10;22(5):398-410. doi: 10.1089/ars.2014.5901. Epub 2014 Apr 15. Review.

PMID:
24635322
30.

Enhanced synthesis and diminished degradation of hydrogen sulfide in experimental colitis: a site-specific, pro-resolution mechanism.

Flannigan KL, Ferraz JG, Wang R, Wallace JL.

PLoS One. 2013 Aug 5;8(8):e71962. doi: 10.1371/journal.pone.0071962. Print 2013.

31.

Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract.

Wallace JL, Flannigan KL, McKnight W, Wang L, Ferraz JG, Tuitt D.

J Physiol Pharmacol. 2013 Apr;64(2):167-75.

32.

Dextran sulfate sodium induces pan-gastroenteritis in rodents: implications for studies of colitis.

Elsheikh W, Flannigan KL, McKnight W, Ferraz JG, Wallace JL.

J Physiol Pharmacol. 2012 Oct;63(5):463-9.

33.

Eukaryotic and prokaryotic contributions to colonic hydrogen sulfide synthesis.

Flannigan KL, McCoy KD, Wallace JL.

Am J Physiol Gastrointest Liver Physiol. 2011 Jul;301(1):G188-93. doi: 10.1152/ajpgi.00105.2011. Epub 2011 Apr 7.

34.

Discomfort and tetracaine.

Li SF, Flannigan K, Lupow J.

Ophthalmology. 2006 Jan;113(1):164. No abstract available.

PMID:
16389117
35.

The evolving role of physician assistants.

Normile HJ, Flannigan K.

Mich Health Hosp. 2000 Mar-Apr;36(2):12-4. No abstract available.

PMID:
11009891
36.
37.

Purine biosynthesis in Escherichia coli K12: structure and DNA sequence studies of the purHD locus.

Flannigan KA, Hennigan SH, Vogelbacker HH, Gots JS, Smith JM.

Mol Microbiol. 1990 Mar;4(3):381-92.

PMID:
2192230
38.

Glycinamide ribonucleotide synthetase from Escherichia coli: cloning, overproduction, sequencing, isolation, and characterization.

Cheng YS, Shen Y, Rudolph J, Stern M, Stubbe J, Flannigan KA, Smith JM.

Biochemistry. 1990 Jan 9;29(1):218-27. Erratum in: Biochemistry 1990 May 29;29(21):5220.

PMID:
2182115
39.

Reliable five-minute test strip method for identification of Streptococcus pyogenes.

Dealler SF, Campbell L, Kerr KG, McGoldrick J, Flannigan KA, Hawkey PM.

Eur J Clin Microbiol Infect Dis. 1989 Apr;8(4):308-10.

PMID:
2565813
40.

Pharmacokinetics of aztreonam in very low birthweight neonates.

Millar MR, Gorham P, Baxter H, Flannigan K, Congdon P.

Eur J Clin Microbiol. 1987 Dec;6(6):691-2. No abstract available.

PMID:
3440460
41.

Antimicrobial substances in urine of patients attending department of genitourinary medicine.

Bignell CJ, Flannigan K, Millar MR.

Genitourin Med. 1986 Aug;62(4):264-6.

42.
43.

Development of tonic immobility in the rabbit: relation to body temperature.

Whishaw IQ, Flannigan KP, Barnsley RH.

Dev Psychobiol. 1979 Nov;12(6):595-605.

PMID:
510799
44.

Gastric pathology and feeding deficits induced by hypothalamic damage in rats: effects of lesion type, size, and placement.

Schallert T, Whishaw IQ, Flannigan KP.

J Comp Physiol Psychol. 1977 Jun;91(3):598-610.

PMID:
267084

Supplemental Content

Loading ...
Support Center